KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 73 filers reported holding KALA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -33.3% | 19,050 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -97.2% | 19,050 | -87.5% | 0.00% | – |
| Q1 2022 | $211,000 | +12.2% | 152,803 | -1.3% | 0.00% | – |
| Q4 2021 | $188,000 | -62.0% | 154,764 | -18.1% | 0.00% | – |
| Q3 2021 | $495,000 | -47.9% | 188,931 | +5.4% | 0.00% | – |
| Q2 2021 | $950,000 | -17.5% | 179,289 | +4.9% | 0.00% | – |
| Q1 2021 | $1,152,000 | -2.8% | 170,986 | -2.1% | 0.00% | – |
| Q4 2020 | $1,185,000 | -14.3% | 174,695 | -5.2% | 0.00% | – |
| Q3 2020 | $1,383,000 | -42.3% | 184,324 | -19.1% | 0.00% | -100.0% |
| Q2 2020 | $2,396,000 | +72.7% | 227,905 | +44.3% | 0.00% | – |
| Q1 2020 | $1,387,000 | +333.4% | 157,900 | +82.8% | 0.00% | – |
| Q4 2019 | $320,000 | -13.7% | 86,369 | -11.5% | 0.00% | – |
| Q3 2019 | $371,000 | -26.7% | 97,541 | +23.1% | 0.00% | – |
| Q2 2019 | $506,000 | +4.3% | 79,261 | +35.1% | 0.00% | – |
| Q1 2019 | $485,000 | +71.4% | 58,661 | +1.3% | 0.00% | – |
| Q4 2018 | $283,000 | -27.2% | 57,911 | +46.8% | 0.00% | – |
| Q3 2018 | $389,000 | -31.5% | 39,447 | -4.5% | 0.00% | – |
| Q2 2018 | $568,000 | +7.0% | 41,327 | +23.2% | 0.00% | – |
| Q1 2018 | $531,000 | +29.8% | 33,543 | +51.6% | 0.00% | – |
| Q4 2017 | $409,000 | -24.3% | 22,127 | -6.3% | 0.00% | – |
| Q3 2017 | $540,000 | – | 23,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,333,333 | $5,073,000 | 100.00% |
| CAXTON CORP | 1,483,343 | $5,644,000 | 6.36% |
| Polaris Venture Management Co. V, L.L.C. | 1,197,032 | $4,555,000 | 2.59% |
| RA Capital Management | 4,537,478 | $17,265,000 | 1.03% |
| Orbimed Advisors | 3,447,840 | $13,119,000 | 0.25% |
| Matisse Capital | 46,500 | $177,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 332,831 | $1,266,000 | 0.22% |
| Sofinnova Investments, Inc. | 478,206 | $1,819,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $377,000 | 0.16% |
| ALGERT GLOBAL LLC | 47,195 | $180,000 | 0.07% |